CASE BRIEF : European Commission vs. Union of India

This case brief discusses the Delhi High Court’s decision in European Commission vs Union of India regarding the restoration of patent applications deemed abandoned due to procedural lapses. The judgment underscores the importance of judicial discretion in exceptional circumstances under Indian patent law.

Read more about CASE BRIEF : European Commission vs. Union of India

After Natco, Bajaj Healthcare files compulsory license against Eli Lilly; EPO Enlarged Board of Appeal issues decision on ‘double patenting’ and more

Bajaj Healthcare has applied for a compulsory license against Eli Lilly for Baricitinib, citing affordability concerns. The post also covers the EPO’s decision on double patenting, updates from the IP5 meeting on AI patents, and new initiatives by WHO, WTO, and WIPO.

Read more about After Natco, Bajaj Healthcare files compulsory license against Eli Lilly; EPO Enlarged Board of Appeal issues decision on ‘double patenting’ and more

Searching for Patents and Patentability of AI and Software Inventions: Session 2 of the Masterclass on IP

This session of the masterclass explored patentability criteria and search strategies for AI and software inventions. Attendees learned about the patent process, prior art search, and practical considerations for Indian innovators. The session offered valuable guidance on intellectual property for startups.

Read more about Searching for Patents and Patentability of AI and Software Inventions: Session 2 of the Masterclass on IP

In Support of Prof. Arul Scaria on Compulsory Licensing for COVID Vaccines, Medicines, Diagnostics and other Technologies

The article examines India’s policy on compulsory licensing for COVID-related medical technologies, echoing Prof. Arul Scaria’s critique of current government inaction. It highlights the legal and historical basis for compulsory licensing and argues for its strategic use to ensure public access to vaccines and medicines.

Read more about In Support of Prof. Arul Scaria on Compulsory Licensing for COVID Vaccines, Medicines, Diagnostics and other Technologies

IPO notifies Supreme Court’s latest decision on ‘Extension of Limitation’; Monsanto and Nuziveedu settle long standing patent dispute and more

This post examines the latest Supreme Court directions on limitation extension, the resolution of the Monsanto-Nuziveedu patent dispute, and ongoing developments at the EPO. It also discusses European parliamentary support for a temporary patent waiver proposed by India and South Africa.

Read more about IPO notifies Supreme Court’s latest decision on ‘Extension of Limitation’; Monsanto and Nuziveedu settle long standing patent dispute and more